Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi‐Afjadi
Topics & Concepts
Erythropoietin-producing hepatocellular (Eph) receptorEphrinCoronavirus disease 2019 (COVID-19)EPH receptor A2ReceptorDownstream (manufacturing)Targeted therapyMedicine2019-20 coronavirus outbreakBiologySignal transductionCancer researchBioinformaticsCancerVirologyInternal medicineCell biologyDiseaseReceptor tyrosine kinaseInfectious disease (medical specialty)Operations managementOutbreakEconomicsAxon Guidance and Neuronal SignalingApelin-related biomedical researchCancer Mechanisms and Therapy